<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260427377891/en/OGN-Stock-Alert-Halper-Sadeh-LLC-is-Investigating-Whether-Organon-Co.-is-Obtaining-a-Fair-Price-for-its-Shareholders/">OGN Stock Alert: Halper Sadeh LLC is Investigating Whether Organon &amp; Co. is Obtaining a Fair Price for its Shareholders</a>
    </div>

      <div class="me-0 me-md-5">
        NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Organon &amp; Co. (NYSE: OGN) to Sun Pharmaceutical Industries Limited for $14.00 per share.Halper Sadeh encourages Organon shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Barrons</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.barrons.com/articles/organon-stock-takeover-sun-parmaceutical-1f71698a">Organon Stock Soars After Sun Seals Takeover. Why Pharma M&amp;A Is a Hot Play.</a>
    </div>

      <div class="me-0 me-md-5">
        India&#39;s Sun Pharmaceutical Industries agrees to buy the women&#39;s health company for $14 a share in an all-cash deal.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">PRNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-organon--co-is-obtaining-a-fair-price-for-public-shareholders-302753848.html">Shareholder Alert: Ademi LLP investigates whether Organon &amp; Co. is obtaining a Fair Price for Public Shareholders</a>
    </div>

      <div class="me-0 me-md-5">
        MILWAUKEE, April 27, 2026 /PRNewswire/ -- Ademi LLP is investigating Organon (NYSE: OGN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Sun Pharma. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Invezz</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://invezz.com/news/2026/04/27/why-is-sun-pharma-betting-11-75b-on-a-struggling-us-drugmaker/?utm_source=snapi">Why is Sun Pharma betting $11.75B on a struggling US drugmaker?</a>
    </div>

      <div class="me-0 me-md-5">
        In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon &amp; Co. for $14 a share in an all-cash deal valued at $11.8 billion The logic of the deal is easy to state and harder to execute as Sun is not buying a fast-growing asset, but a scaled global platform with meaningful cash flow, a large commercial footprint and ...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">CNBC</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.cnbc.com/2026/04/27/indian-drugmaker-sun-pharma-to-buy-us-firm-organon-in-11point75-billion-deal.html">Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal</a>
    </div>

      <div class="me-0 me-md-5">
        Sun Pharmaceutical Industries will acquire New Jersey-based Organon &amp; Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">WSJ</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.wsj.com/business/deals/sun-pharmaceutical-to-acquire-organon-valued-at-11-75-billion-8c3e0f65">Sun Pharmaceutical to Acquire Organon Valued at $11.75 Billion</a>
    </div>

      <div class="me-0 me-md-5">
        India&#39;s Sun Pharmaceutical Industries 524715 -3.57%decrease; red down pointing triangle has agreed to acquire U.S.-listed healthcare company Organon OGN 30.93%increase; green up pointing triangle &amp; Co. for an enterprise value of $11.75 billion.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positive
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Reuters</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.reuters.com/business/healthcare-pharmaceuticals/sun-pharma-acquire-organon-1175-bln-all-cash-deal-2026-04-27/">Sun Pharma to acquire Organon in $11.75 bln all-cash deal</a>
    </div>

      <div class="me-0 me-md-5">
        Sun Pharmaceutical ​Industries ‌will acquire Organon &amp; ​Co ​in an ⁠all‑cash ​deal, ​valuing the U.S. drugmaker ​at ​about $11.75 billion, ‌the ⁠companies said in a ​joint ​statement ⁠on ​Sunday.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/en/stock/Organon-Co-US68622V1061">Organon &amp; Co.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Business Wire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">5 months ago</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.businesswire.com/news/home/20260426881370/en/Sun-Pharma-signs-Definitive-Agreement-to-Acquire-Organon/">Sun Pharma signs Definitive Agreement to Acquire Organon</a>
    </div>

      <div class="me-0 me-md-5">
        MUMBAI, India &amp; JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon &amp; Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shar...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/en/news/Organon-Co-US68622V1061/load_more?page=4">
      Show more News
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>